AI Summary Hereditary hemochromatosis is an inherited condition, most often linked to HFE gene changes, that makes the body absorb too much iron. The extra iron can build up in the liver, heart, pancreas, and joints. Early signs include joint pain and fatigue, but many people have no symptoms for years. Iron blood tests and a genetic test confirm it. Regular blood removal (phlebotomy) is the main treatment, and relatives should consider screening.
Source: www.liverdirectory.com
Medically Reviewed.
Hereditary hemochromatosis (HH) is a genetic disorder that causes the body to absorb far more iron from food than it needs — on average 5 to 20 times too much. Because the body has no way to remove the excess, iron builds up in the liver, heart, pancreas, and joints over time.
Most cases are caused by inherited mutations in the HFE gene. HH often causes no symptoms for years, and many people are found only through routine blood work or testing prompted by a family member's diagnosis. Fewer than 10% of people with the genetic mutation go on to develop severe organ damage.
There is no cure, but hereditary hemochromatosis is very treatable when caught early. Regular phlebotomy (blood removal) lowers iron to safe levels and, for most people, prevents serious complications in the liver, heart, and pancreas.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
About Hereditary Hemochromatosis
Hereditary hemochromatosis (HH) is a genetic disorder that causes the body to absorb far more iron from food than it needs — on average 5 to 20 times too much. Because there is no natural way to remove this excess, it builds up in the liver, heart, pancreas, joints, and other organs.
Most cases are caused by mutations in the HFE gene, which normally helps regulate hepcidin, the hormone that controls how much iron the intestines absorb. The classic mutation, C282Y, causes the most severe iron overload when inherited from both parents (homozygous); a milder pattern occurs with one copy of C282Y paired with the H63D mutation, or two copies of H63D. Rarer non-HFE forms — including juvenile hemochromatosis (hemojuvelin or hepcidin gene mutations), TfR2 mutations, and ferroportin disease — follow the same pathway of unregulated iron absorption.
HH is one of the most common inherited disorders in people of Northern European descent, affecting roughly 1 in 220 to 250 people in this group. Despite this, fewer than 10% of people with the genetic susceptibility develop severe iron overload with organ damage, and many are now identified through routine lab screening or family testing before symptoms ever appear.
How Hereditary Hemochromatosis May Feel
Hereditary hemochromatosis is often called a silent condition. Many people have no symptoms for years, and when symptoms do appear, they are easy to mistake for other conditions.
Getting Checked
Hereditary hemochromatosis is diagnosed through a combination of blood tests that measure iron levels and, when needed, genetic testing or a liver biopsy to confirm the diagnosis and check for liver damage.
A transferrin saturation above 45% or an elevated serum ferritin should prompt HFE genetic testing to confirm hereditary hemochromatosis.
Care & Management
Treatment for hereditary hemochromatosis focuses on removing excess iron from the body before it can damage organs. Regular monitoring ensures iron levels stay in a safe range for life.
Therapeutic phlebotomy is the first-line treatment. During an induction phase, roughly 450-500 mL of blood is removed weekly or every 1-2 weeks until ferritin reaches target levels. A maintenance phase then continues every 2-4 months for life, with iron studies checked regularly to guide frequency.
Iron chelation medicines such as deferasirox, deferoxamine, or deferiprone bind excess iron so the body can eliminate it. These are reserved for people who cannot tolerate phlebotomy, such as those with inaccessible veins, severe needle phobia, anemia, or life-threatening cardiac iron overload. Oral deferasirox should not be used in patients with advanced liver disease.
Therapeutic phlebotomy remains the cornerstone of treatment: it is safe, low-cost, and reduces the risk of cirrhosis, heart problems, and diabetes when started before organ damage occurs.
Hereditary hemochromatosis develops when inherited gene mutations disrupt the body's normal iron regulation, causing the intestines to absorb far more iron than needed.
HFE-related hereditary hemochromatosis is the most common identified genetic disorder in Caucasians, especially those of Northern European descent, affecting roughly 1 in 220 to 250 people.
When to Get Checked
Hereditary hemochromatosis often develops silently, so many people are unaware they have it until a routine blood test or a family member's diagnosis prompts screening. Getting evaluated early gives you the best chance of preventing organ damage.
Talk with a healthcare provider if you have a first-degree relative (parent or sibling) with hemochromatosis, persistent unexplained fatigue or joint pain, or a family history of unexplained liver disease, arthritis, or impotence. You should also seek evaluation if routine blood work shows an elevated transferrin saturation or serum ferritin.
Because hereditary hemochromatosis is genetic, first-degree relatives of someone diagnosed with the condition are encouraged to get iron studies and, if appropriate, HFE genetic testing, even if they feel completely well.
A gastroenterologist or hepatologist can confirm the diagnosis, assess how much iron has accumulated, and guide phlebotomy scheduling and long-term monitoring.
Find doctors who treat hereditary hemochromatosis and connect with a specialist near you.
Eating & Liver Health
Diet supports hereditary hemochromatosis treatment but does not replace phlebotomy or chelation therapy. Iron from food adds to the body's total iron burden, so food choices matter.
Guidance recommends moderating red meat and iron-fortified foods and eating plenty of fruits and vegetables. Vitamin C increases how much iron the body absorbs from food. Some physicians recommend tea or coffee with meals, which can reduce iron absorption.
Alcohol and iron together accelerate liver scarring. Raw shellfish can carry Vibrio vulnificus and other iron-loving bacteria, which can cause severe, sometimes fatal infections in people with iron overload.
Nutrition habits to discuss with your care team
Common Questions
Yes. Hereditary hemochromatosis is an inherited condition that follows an autosomal recessive pattern. Most cases come from mutations in the HFE gene, which helps control how much iron the intestines absorb. A child must inherit a mutated copy from each parent to be at highest risk. If both parents carry one copy, each child has a 1 in 4 chance of inheriting two copies. Carrying one copy is common: an estimated 1 in 8 to 12 Americans is a carrier.
No, but it is very treatable. Regular phlebotomy lowers iron to safe levels and, in most people, prevents serious organ damage. Because iron can build up again, treatment usually continues for life. With good care, most symptoms improve over time. Some damage that has already occurred, especially arthritis and joint pain, often remains even after iron levels return to normal. Starting treatment before cirrhosis or diabetes develops gives the best results.
No. Fewer than 10% of people with the genetic mutation develop severe iron overload with organ damage. Many never develop significant iron overload. Having two copies of C282Y carries the highest risk, and symptoms usually do not appear until middle age. Because no one can predict who will be affected, doctors rely on blood tests, such as transferrin saturation and serum ferritin, to track iron levels over time rather than assuming the mutation will cause harm.
Therapeutic phlebotomy, the regular removal of blood, is the first-line treatment. About 450 to 500 mL of blood is removed, similar to a blood donation, and the visit usually takes 10 to 20 minutes. At first, treatment happens about once a week or every 1 to 2 weeks until ferritin reaches the target range set by your care team. Treatment then moves to a maintenance phase, usually every 2 to 4 months, adjusted by iron tests. Some people feel tired or lightheaded afterward, and overtreatment can cause mild anemia, so your team checks your levels before each session.
Doctors diagnose it with blood tests, and sometimes a genetic test or biopsy. The first step is usually a transferrin saturation test and a serum ferritin test. A transferrin saturation above 45% is considered abnormal. If results are abnormal, an HFE genetic test checks for the C282Y and H63D mutations. If the mutation is not found, the doctor looks for other causes. A liver biopsy is used less often now. It may be recommended to check for advanced scarring or cirrhosis in people with a high ferritin level or other risk factors.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
